Hepatitis C Pricing: Insurers' Cost Benchmarks Would Yield Optimal Price Of $42,000 – Report

Institute for Clinical and Economic Review reviews how insurers determine when a drug price would require premium increases or coverage restrictions, and suggests $34,000 to $42,000 would be a manageable price range for new hepatitis C treatments based on budget thresholds widely used by payers.